Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||- / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Headache, Malaise, Hot flush
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:
Write-up: Flush hot; Generally unwell; Headache; This is a spontaneous report from a contactable consumer received from the Regulatory Agency. The regulatory authority report number is GB-MHRA-WEBCOVID-202106061044065090-1Z6HT, Safety Report Unique Identifier is GB-MHRA-ADR 25426993. An 85-year-old male patient received second dose of BNT162B2 (COVID-19 MRNA VACCINE BIONTECH), via an unspecified route of administration on 03Jun2021 as single dose for COVID-19 immunisation. Co-suspect drug SARS-COV-2 VIRUS was reported. Medical history included clinical trial participant. He has not had symptoms associated with COVID-19 and not had a COVID-19 test. The patient''s concomitant medications were not reported. The patient experienced flush hot, generally unwell, and headache on 04Jun2021. He has not tested positive for COVID-19 since having the vaccine. The patient was recovering from flush hot while outcome of other events was not recovered. Case was reported as serious by health authority (hospitalization). No follow-up attempts are needed, information about batch number cannot be obtained. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166